Bioterrorist Battles

A Swiss-based firm may have a back-door way to thwart a bioterrorist attack—by fighting the flu.

Written byFran Hawthorne
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

ISTOCKPHOTO.COM, NULLPLUS

In 2001, the Center for Strategic and International Studies (CSIS) and the Johns Hopkins Center for Civilian Biodefense Studies coordinated a 2-day terrorist attack simulation using the smallpox virus, called “Dark Winter.” The predicted result: up to one million people would die within weeks. Similarly, an analysis by the National Security Council in November 2009 estimated that a biological attack could leave “hundreds of thousands of people” at risk of death. Of course, all these estimates are iffy, and the CSIS-Johns Hopkins prediction in particular was based on a relatively high transmission rate of 10 new infections by each victim—a figure that depends on unpredictable factors such as the weather, time of year, social interactions, and each victim’s genetic makeup and health. Nevertheless, there is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies